JPRN-UMIN000038934已完成未知
Multi center observational study of resistance mechanisms to alectinib in patients with ALK-rearranged, unresectable, locally advanced or metastatic non-small cell lung cancer - ALCURE(ALeCtinib Ultimate REsistance mechanisms study)
Japanese Foundation for Cancer Research / CHUGAI PHARMACEUTICAL CO., LTD.0 个研究点目标入组 200 人开始时间: 2019年12月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who are judged by physician in charge of a case to be inappropriate to participate in study.
研究者
相似试验
招募中
不适用
Tracking Artemisinin Resistance in India.CTRI/2015/10/006243ational Institute of Malaria ResearchICMR140
已完成
不适用
To detect artesunate resistance in uncomplicated Plasmodium falciparum malaria patientsCTRI/2016/05/006964Department for International Development1,800
招募中
不适用
Retrospective cohort study of resistance associated substitutions and clinical course in Glecaprevir(GLE)/Pibrentasvir(PIB) treatment to hepatitis C virusHepatitis C virus infected patientsJPRN-UMIN000027428Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology700
已完成
不适用
Prospective study to investigate the resistant mechanism to afatinib treatment in EGFR mutation-positive non-small cell lung cancerung CancerJPRN-UMIN000031845Kagoshima University Hospital26
已完成
不适用
The study to evaluate the efficacy and resistance for EGFR-TKIs treatment in lung cancer patients.lung cancerJPRN-UMIN000002193Second Department of Internal Medicine, Nagasaki University hospital60